Skip to main content

Advertisement

Table 1 Table 1

From: An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study

A   
Baseline characteristics for men. Data are reported as median and range
  Chronic viral hepatitis patients (n = 36) Control Subjects (n = 17)
Age (years) 45.5 (19,73) 62.5 (21,79)
Height (cm) 173 (160,190) 173 (167,186)
Weight (kg) 81.5 (58,118) 75 (62,100)
BMI (kg/m 2 ) 26.3 (20.3,36.2) 25.1 (21.5, 29.5)
FMI 9.99 (5.5, 17.4) 9.09 (6.39, 12.4)
Glucose (mg/dl) 96.5 (70,147)* 88 (60,183)
Insulin (μU/mL) 7.34 (0.73, 125.8) 9.18 (3.05,17.28)
HOMA-IR 2 (0.12–7.36) 2 (0.88–4.89)
AST (IU/l) 59 (19,274)* 26 (21,35)
ALT (IU/l) 105 (24,366)* 25 (20,36)
Leptin (pg/ml) 5134 (695,30430) 5054 (588,15325)
B   
Baseline characteristics for women. Data are reported as median and range
  Chronic viral hepatitis patients (n = 14) Control Subjects (n = 15)
Age (years) 38 (16,70) 51 (20,74)
Height (cm) 165 (156,169) 160 (153,168)
Weight (kg) 77 (51,112) 74 (60,94)
BMI (kg/m 2 ) 29.7 (18,39.3) 29.5 (23.1,38.8)
FMI 12.6 (3.81,19.7) 12.4 (7.59,17.39)
Glucose (mg/dl) 80.5 (70,175) 81 (60,156)
Insulin (μU/mL) 5.65 (0.73,16.47) 8.43 (5.67,67.76)
HOMA-IR 1.02 (0.12, 6.25) 1.53 (0.95–13.5)
AST (IU/l) 55 (38,129)* 27 (20,35)
ALT (IU/l) 66 (54,269)* 27 (21,32)
Leptin (pg/ml) 11372(1714,43605) 18990(4876,48928)
  1. *p < 0.05 vs controls